Pathstone Holdings’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
PCM
Pathstone Holdings's BCAT Position: Q2 2025 in Review
Pathstone Holdings sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2025, closing a stake of 143,719 shares — an estimated $2.22M sold.
Pathstone Holdings first reported a position in BCAT in Q4 2023 and held it in 6 quarters. The position peaked at $38.1M in Q1 2024. 91 funds tracked by Wall St. Rank hold BCAT as of Q2 2025.
- Pathstone Holdings reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2025 after selling out during the quarter.
- Pathstone Holdings sold 143,719 BlackRock Capital Allocation Term Trust shares in Q2 2025, an estimated $2.22M.
- Pathstone Holdings first reported a position in BlackRock Capital Allocation Term Trust in Q4 2023 and held it in 6 quarters.
- Pathstone Holdings's BlackRock Capital Allocation Term Trust position peaked at $38.1M in Q1 2024.
- 91 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2025.
Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.